tm logo

Monitor this mark

View On USPTO

JOIZEMO
Live/Pending
RESPONSE AFTER NON-FINAL ACTION - ENTERED

final action

on 29 Nov 2024

Last Applicant/ Owned by

Sage Therapeutics Inc.

215 First Street

Cambridge

MA

02142

Serial Number

98373320 filed on 24th Jan 2024

Registration Number

N/A

Correspondent Address

Steven A. Abreu

Steven A. Abreu Sunstein LLP

Boston, MA 02110

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

JOIZEMO

Pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders, neurological diseases and disorders

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders, neurological diseases and disorders

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 98373320

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 4362/2052

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
29th Nov 2024TEAS/EMAIL CORRESPONDENCE ENTERED
26th Nov 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
26th Nov 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
09th Sep 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
09th Sep 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
11th Jun 2024NON-FINAL ACTION WRITTEN
11th Jun 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
11th Jun 2024ASSIGNED TO EXAMINER
11th Jun 2024NON-FINAL ACTION E-MAILED
26th May 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED